Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q4 FY24 results · Jan–Mar 2024
Amrutanjan Health Care reported revenue from operations of ₹127.06 crore (up 26.7% from Q4 FY23) and net profit of ₹13.66 crore (up 7.6% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a standalone basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 127.06 | 100.32 | +26.7% | 116.99 | +8.6% |
| Other income | 5.54 | 4.82 | +15.0% | 3.76 | +47.3% |
| Total income | 132.61 | 105.14 | +26.1% | 120.76 | +9.8% |
| Profit before tax | 19.60 | 16.47 | +19.0% | 23.71 | −17.3% |
| Net profit for the period | 13.66 | 12.70 | +7.6% | 17.45 | −21.7% |
| EPS, basic (₹) | 4.72 | 4.35 | +8.5% | 6.05 | −22.0% |
| Net margin (%) | 10.7 | 12.7 | 14.9 |
Standalone
- Filed with BSE
- 13 Jun 2024, 15:45 IST
- Board meeting
- 23 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE